ANOVA BLCA result package
Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-04-08 10:28:13 iorio@ebi.ac.uk
Drug Domain: GDSC1000_paper_set, Analysis Domain: BLCA specific
Individual drug analysis: 228
Drug details and screening numbers
Drug Name: KIN001-102
Drug ID: 228
Synonyms:
Brand name:
Target: AKT1
Number of cell lines screened: 925
Screening concentration range(s): 0.04 to 10.24 uM
Statistically significant associations identified = 1
association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a8 |
ARID1A_mut |
228 |
1 |
1 |
KIN001-102 |
AKT1 |
5 |
14 |
2.33 |
2.83 |
4.8 |
1.97 |
2.1 ** |
1.9 * |
3.2 ** |
9.29e-04 |
NA |
NA |
24 |
All-tests volcano plot